{"database": "lobbying", "table": "lobbying_activities", "rows": [[2149486, "b6f0318f-7a57-4f87-a1c5-92ea2d627199", "Q2", "SPLITOAK STRATEGIES LLC", 401104582, "CARIS SCIENCE INC", 2018, "second_quarter", "MED", "FDA oversight of Next Generation Sequencing technology for advanced cancers. Medicare coverage of Next Generation Sequencing technology for advanced cancers. Finalize PAMA reform of Medicare clinical lab payments.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2018-07-18T10:58:20.507000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2149486"], "units": {}, "query_ms": 248.70772298891097, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}